Vinge advises Procuritas Capital Investor VII (“Procuritas”) in connection with its acquisition of PropTech Sweden AB (“PropTech Sweden”) and its subsidiaries Axcell Fastighetspartner AB (“Axcell Fastighetspartner AB”) and Ömangruppen Svenska AB (“Ömangruppen”).

PropTech Sweden is the parent company of Ömangruppen and Axcell Fastighetspartner, two leading companies in indoor climate, energy efficiency, and property management. With over 300 employees and 30 local offices in southern Sweden, Luleå and Örnsköldsvik, the group acts as a close partner to property owners who want to increase energy efficiency or optimize the operation of their property in other ways. Procuritas has since its founding in 1986 completed more than 50 investments and hundreds of add-on acquisitions in the Nordic region. As real estate accounts for 40% of Sweden's total energy consumption, Procuritas considers PropTech Sweden a vital player in the climate transition, especially in view of upcoming EU regulations on reduced emissions. Completion of the acquisition is subject to customary competition clearance.

Vinge’s team mainly consisted of Jonas JohanssonMaria Dahlin Kolvik, Clara Sohlberg, Eskil Nyström (M&A), Karl-Gustaw Tobola (Banking and Finance), Daniel Prawitz, Mario Saad, Clara Klingspor (Corporate Commercial), Julia Löfqvist (Compliance), Petronella Hallberg, Amelia Rihs (Employment) Lina Österberg (Environment), Mathilda Persson, Alva Skott (IT & GDPR), Alexandra Tamm (Real Estate), Kristoffer Sällfors (Public Procurement) and Johan Walhbom (EU, Competition and Regulatory).

Related

Vinge has advised Egetis Therapeutics in connection with a directed share issue

Vinge has advised Egetis Therapeutics AB (publ) (“Egetis Therapeutics”), listed on Nasdaq Stockholm, in connection with a directed share issue whereby Egetis Therapeutics raised proceeds of approximately SEK 183 million before transaction costs.
October 06, 2025

Vinge worked with funds advised by Agilitas on the buy-out of Vivicta (previously Tietoevry Tech Services), including on the issuance of senior secured bonds and on entering into a super senior RCF

Vinge, together with O’Melveny as lead counsel and Avance, worked with funds advised by Agilitas Private Equity LLP (“Agilitas”), the pan-European mid-market private equity firm, in their backing of Vivicta. The buy-out was previously announced on 24 March 2025 and closed on 2 September 2025.
October 03, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 671.5 million

Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue through which the company raises proceeds of approx. SEK 671.5 million before transaction costs.
October 03, 2025